Loading...
Market
Primary focus of discourse on Pfizer documents by mid-2025?
2
Resolution / Starting Odds
Vaccine Safety • 25%
Data Transparency • 25%
FDA's Handling • 25%
Effectiveness of Vaccines • 25%
Analysis of public discourse through media publications and social media trends
Story
FDA Ordered to Release Over a Million Pages of Pfizer's Vaccine Trial Documents in Transparency Win
Dec 7, 2024, 01:39 AM
A U.S. federal judge has ordered the Food and Drug Administration (FDA) to release an additional million pages of documents related to Pfizer's COVID-19 vaccine trials. This decision follows a lawsuit filed by Aaron Siri, who has been advocating for transparency in the vaccine approval process. The FDA had previously attempted to keep these documents hidden from the public for 75 years, citing the need for time to process the extensive data. The court's ruling marks a significant victory for transparency, as it compels the FDA to disclose information underpinning its authorization of the vaccines, despite the agency's efforts to end the public records lawsuit.
View original story
Similar markets
Trial participant demographics • 25%
Vaccine efficacy data • 25%
Adverse side effects • 25%
Regulatory approval process • 25%
Increased transparency and trust • 25%
Legal challenges against FDA • 25%
Policy changes in vaccine approval • 25%
No significant impact • 25%
CDC • 25%
WHO • 25%
FDA • 25%
Pfizer • 25%
Public Health Organizations • 25%
FDA • 25%
No major impact on any organization • 25%
Pfizer • 25%
Increased demand for transparency • 25%
Decreased trust in vaccines • 25%
Increased trust in vaccines • 25%
Indifference • 25%
Increase trust • 25%
No significant change • 25%
Mixed impact • 25%
Decrease trust • 25%
Enhanced oversight • 25%
Funding restrictions • 25%
Increased transparency • 25%
No major changes • 25%